Avedon Capital, a private equity growth investor, completed the acquisition of a stake in FormMed, a developer and supplier of micronutrition for therapeutic use. Financial terms were not disclosed. ”We perceive FormMed as superior due to its unique go-to-market model which relies on therapists as the ultimate advocate of FormMed as the most trusted treatment methodology in the field of micronutrition. The ongoing trust and support of FormMed’s partners convinced us to have found a strong and recurring base from which we build on in supporting the business in growing further beyond its current home markets,” Philip Fischer, Avedon Investment Director.